Alistair R. Grey

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

Journal: JAMA oncology
Published: February 12, 2026

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries.

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries.

Journal: European urology
Published: January 21, 2026

Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study.

Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study.

Journal: European urology
Published: October 14, 2024

A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.

A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.

Journal: European journal of radiology
Published: February 07, 2023

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.

Journal: Radiology
Published: December 13, 2022

Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.

Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.

Journal: European urology focus
Published: November 22, 2022

Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing.

Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing.

Journal: BJUI compass
Published: October 21, 2022

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.

Journal: Frontiers in oncology
Published: October 03, 2022

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.

Journal: Radiology
Published: August 02, 2022

Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models.

Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models.

Journal: Diagnostics (Basel, Switzerland)
Published: May 25, 2022

Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer.

Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer.

Journal: BMJ open
Published: April 09, 2022

Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.

Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.

Journal: The Lancet. Oncology
Published: August 27, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026